Skip to main content
FDA officials highlight patient engagement initiatives
2/11/2020

FDA officials whose focus areas include patient engagement participated in a National Organization for Rare Disorders webcast to teach patients how to make their voices heard in drug development and regulatory decision-making. Patient-focused venues at the FDA include the Patient Engagement Collaborative, the Patient Engagement Advisory Committee, the Rare Disease Coordinating Committee, the Science of Patient Input Initiative and patient engagement workshops and listening sessions.

Full Story: